90 FR 13 pg. 7657 - Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
Type: NOTICEVolume: 90Number: 13Page: 7657
Page: 7657Docket number: [B-50-2024]
FR document: [FR Doc. 2025-01478 Filed 1-21-25; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-50-2024]
Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
On September 18, 2024, Merck, Sharp & Dohme LLC submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 49Y, in Rahway, New Jersey.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (89 FR 78845, September 26, 2024). On January 16, 2024, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including section 400.14.
Dated: January 16, 2025.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2025-01478 Filed 1-21-25; 8:45 am]
BILLING CODE 3510-DS-P